These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18286527)

  • 1. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
    Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
    Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
    Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
    J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.
    McCarthy AL; Shaban RZ; Gillespie K; Vick J
    Support Care Cancer; 2014 May; 22(5):1375-83. PubMed ID: 24362908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis.
    Huang KL; Lin KY; Huang TW; Loh EW; Hua YM; Su HC; Tam KW
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13118. PubMed ID: 31184794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
    Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F
    Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.
    Kim JY; Ok ON; Seo JJ; Lee SH; Ahn JS; Im YH; Park YH
    Breast Cancer Res Treat; 2017 Aug; 164(3):617-625. PubMed ID: 28488142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-induced nail toxicity: a case of severe onycholysis and topic review.
    Lau CP; Hui P; Chan TC
    Chin Med J (Engl); 2011 Aug; 124(16):2559-60. PubMed ID: 21933605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.
    Ishiguro H; Takashima S; Yoshimura K; Yano I; Yamamoto T; Niimi M; Yamashiro H; Ueno T; Takeuchi M; Sugie T; Yanagihara K; Toi M; Fukushima M
    Support Care Cancer; 2012 Sep; 20(9):2017-24. PubMed ID: 22086405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas.
    Ferreira O; Baudrier T; Mota A; Duarte AF; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):296-9. PubMed ID: 20608863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis.
    Begon E; Blum L; Fraboulet G; Assouad S; Bachmeyer C
    Eur J Dermatol; 2011; 21(4):628-9. PubMed ID: 21697040
    [No Abstract]   [Full Text] [Related]  

  • 12. Nail toxicity induced by cancer chemotherapy.
    Gilbar P; Hain A; Peereboom VM
    J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Onycholysis due to docetaxel in breast cancer treatment].
    Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
    Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.
    Freyer G; Hennebert P; Awada A; Gil T; Kerger J; Selleslags J; Brassinne C; Piccart M; de Valeriola D
    Clin Cancer Res; 2002 Jan; 8(1):95-102. PubMed ID: 11801544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly.
    ten Tije AJ; Verweij J; Carducci MA; Graveland W; Rogers T; Pronk T; Verbruggen MP; Dawkins F; Baker SD
    J Clin Oncol; 2005 Feb; 23(6):1070-7. PubMed ID: 15718305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe nail changes due to Docetaxel treatment.
    Rafi L; Friedrich M; Tilgen W; Reichrath J
    Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison.
    Johnson K; Stoffel B; Schwitter M; Hayoz S; Rojas Mora A; Fischer Maranta A; El Saadany T; Hasler U; von Moos R; Patzen A; Mark M; Roberts G; Cathomas R
    Support Care Cancer; 2024 Jul; 32(8):554. PubMed ID: 39066890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of dose-dense docetaxel followed by doxorubicin with cyclophosphamide as adjuvant therapy for breast cancer in a phase II study.
    Lambert-Falls R; Modugno S
    Clin Breast Cancer; 2007 Aug; 7(9):697-704. PubMed ID: 17919350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
    Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
    J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.